The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1
Authors
Keywords
-
Journal
BIOMETALS
Volume 25, Issue 4, Pages 795-803
Publisher
Springer Nature
Online
2012-02-02
DOI
10.1007/s10534-012-9525-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
- (2017) Sandro Altamura et al. JOURNAL OF ALZHEIMERS DISEASE
- Effect of mitochondrial complex I inhibition on Fe–S cluster protein activity
- (2011) Natalia P. Mena et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differential effects of insulin on peripheral diabetes-related changes in mitochondrial bioenergetics: Involvement of advanced glycosylated end products
- (2011) Aline Pertile Remor et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Etiology and pathogenesis of Parkinson's disease
- (2011) Anthony H. Schapira et al. MOVEMENT DISORDERS
- Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples
- (2010) Douglas B. Kell ARCHIVES OF TOXICOLOGY
- Complex I: Inhibitors, inhibition and neurodegeneration
- (2010) A.H.V. Schapira EXPERIMENTAL NEUROLOGY
- Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease
- (2010) Lauren Broom et al. FREE RADICAL BIOLOGY AND MEDICINE
- Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson’s disease
- (2010) Zhanyun Lv et al. JOURNAL OF NEURAL TRANSMISSION
- The relevance of iron in the pathogenesis of Parkinson’s disease
- (2010) Jeswinder Sian-Hülsmann et al. JOURNAL OF NEUROCHEMISTRY
- Aminochrome Induces Disruption of Actin, Alpha-, and Beta-Tubulin Cytoskeleton Networks in Substantia-Nigra-Derived Cell Line
- (2010) Irmgard Paris et al. NEUROTOXICITY RESEARCH
- Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
- (2010) Francisco Pan-Montojo et al. PLoS One
- Iron supply determines apical/basolateral membrane distribution of intestinal iron transporters DMT1 and ferroportin 1
- (2009) Marco T. Núñez et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease
- (2009) Ning Song et al. FREE RADICAL BIOLOGY AND MEDICINE
- Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
- (2008) J. Salazar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepcidin inhibits apical iron uptake in intestinal cells
- (2007) Natalia P. Mena et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Mitochondria deficient in complex I activity are depolarized by hydrogen peroxide in nerve terminals: relevance to Parkinson's disease
- (2003) Christos Chinopoulos et al. JOURNAL OF NEUROCHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started